Furthermore, neurogranin and other synaptic biomarkers such as Rab3 and SNAP25 were found to predict cognitive decline in patients with Alzheimer’s disease and dementia of Lewy bodies. The gene discussed is NRGN; the disease is Alzheimer disease.